Home Cart Sign in  
Chemical Structure| 2259648-80-9 Chemical Structure| 2259648-80-9

Structure of Mezigdomide
CAS No.: 2259648-80-9

Chemical Structure| 2259648-80-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CC-92480 is a cereblon E3 ubiquitin ligase modulating drug (CELMoD). CC-92480 shows high affinity to cereblon, resulting in potent antimyeloma activity .

Synonyms: CC-92480

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Mezigdomide

CAS No. :2259648-80-9
Formula : C32H30FN5O4
M.W : 567.61
SMILES Code : N#CC1=CC=C(N2CCN(CC3=CC=C(COC4=CC=CC5=C4CN([C@@H](CC6)C(NC6=O)=O)C5=O)C=C3)CC2)C(F)=C1
Synonyms :
CC-92480
MDL No. :MFCD32263041
InChI Key :YTINZZFBHWSAGL-NDEPHWFRSA-N
Pubchem ID :137379043

Safety of Mezigdomide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Mezigdomide (CC-92480), classified as a cereblon E3 ubiquitin ligase modulating agent (CELMoD), functions as a molecular adhesive. It exhibits a strong binding affinity to cereblon, thereby demonstrating potent antimyeloma activity [1].
Target
  • CRBN

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06318676 Renal Impairment PHASE1 RECRUITING 2025-03-05 PANAX, Miami Lakes, Florida, 3... More >>3014, United States|Omega Research Group - Orlando, Orlando, Florida, 32808, United States|Orlando Clinical Research Center OCRC, Orlando, Florida, 32809, United States Less <<
NCT05707390 Hepatic Impairment PHASE1 COMPLETED 2023-09-13 PANAX, Miami Lakes, Florida, 3... More >>3014, United States|Orlando Clinical Research Center OCRC, Orlando, Florida, 32809, United States|The Texas Liver Institute, San Antonio, Texas, 78215, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.81mL

1.76mL

0.88mL

17.62mL

3.52mL

1.76mL

References

 

Historical Records

Categories